FDA commissioner confirms stable appointment by June 2026

Pharma executives emphasize the need for a permanent FDA commissioner to restore regulatory certainty. A stable appointment would signal continuity in drug approval processes, reducing industry uncertainty.

Implied probability (Yes)

75%